triamcinolone acetonide has been researched along with Bacterial Skin Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahrens, K; Bräutigam, M; Fölster-Holst, R; Gläser, R; Harder, J; Jensen, JM; Meingassner, J; Proksch, E; Scherer, A; Schwarz, T; Stütz, A | 1 |
| Qadir, SN; Rahman, SB; Raza, N | 1 |
1 trial(s) available for triamcinolone acetonide and Bacterial Skin Diseases
| Article | Year |
|---|---|
Paederus dermatitis in Sierra Leone.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Anti-Bacterial Agents; Cetirizine; Ciprofloxacin; Coleoptera; Dermatitis, Irritant; Diflucortolone; Female; Glucocorticoids; Humans; Injections, Intralesional; Male; Prednisolone; Sierra Leone; Skin Diseases, Bacterial; Triamcinolone Acetonide | 2006 |
1 other study(ies) available for triamcinolone acetonide and Bacterial Skin Diseases
| Article | Year |
|---|---|
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.
Topics: Adrenal Cortex Hormones; Animals; Antimicrobial Cationic Peptides; Base Sequence; beta-Defensins; Betamethasone Valerate; Calcineurin Inhibitors; Case-Control Studies; Dermatitis, Atopic; Disease Models, Animal; DNA Primers; Fatty Acids, Essential; Gene Expression; Humans; Male; Mice; Mice, Hairless; RNA, Messenger; Skin Diseases, Bacterial; Tacrolimus; Triamcinolone Acetonide | 2011 |